Nora Rose Sudarsan, D.O. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 305 Hospital Dr Fl 2, Glen Burnie, MD 21061 Phone: 410-761-9896 Fax: 410-761-2250 |
Arshia Ashley Soleimani, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 305 Hospital Dr, Glen Burnie, MD 21061 Phone: 410-761-9896 Fax: 410-761-9896 |
Dr. Min Chul Oh, M.D. Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 305 Hospital Dr, Tate Cancer Center, Glen Burnie, MD 21061 Phone: 410-553-8100 Fax: 410-553-8133 |
News Archive
Mount Sinai researchers have shown, for the first time, the complex web of links between physical and behavioral characteristics, like age, body mass index (BMI), and substance use, and specific patterns of brain structure and function in patients with psychosis.
The U.S. Food and Drug Administration has announced manufacturers of certain drugs approved to treat Type 2 diabetes have agreed to add a stronger warning on the risk of heart failure, a condition that occurs when the heart does not adequately pump blood.
Mount Sinai researchers have discovered that Polycomb complexes, groups of proteins that maintain gene expression patterns, are essential for proper skin development, according to a paper published in Genes & Development on February 18.
Opexa Therapeutics, Inc., announced today that its lead drug candidate Tovaxin® has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for the treatment of patients with Secondary Progressive Multiple Sclerosis.
As a community partner of the Canadian Public Health Association, BIOTECanada, on behalf of Canada's biotechnology industry, congratulates the CPHA on 100 years of leadership in public health.
› Verified 8 days ago